Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2013
Evaluating many treatments and biomarkers in oncology: a new design
Richard Kaplan, Timothy Maughan, Angela Crook, et al.
The Lancet. Gastroenterology & Hepatology
|
July 30, 2021
The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study
Raymond Hugo Henderson, Declan French, Timothy Maughan, et al.
Journal of Clinical Pathology
|
September 10, 2015
Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial
Susan D Richman, Richard Adams, Phil Quirke, et al.
British Journal of Cancer
|
June 17, 2022
Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer
Taiki Hashimoto, Daisuke Takayanagi, Junpei Yonemaru, et al.
Scientific Reports
|
September 19, 2019
The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression
Rachael Thomas, Davide Trapani, Lily Goodyer-Sait, et al.
BMC Cancer
|
February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)
Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
Clinical Trials (London, England)
|
August 24, 2017
Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols
Mahesh Kb Parmar, Matthew R Sydes, Fay H Cafferty, et al.
The Lancet. Oncology
|
April 13, 2013
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial
Roger D James, Robert Glynne-Jones, Helen M Meadows, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 20, 2013
A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
Gary Middleton, Sarah Brown, Catherine Lowe, et al.
BMC Cancer
|
April 17, 2015
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma
Somnath Mukherjee, Christopher N Hurt, Sarah Gwynne, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2013
Evaluating many treatments and biomarkers in oncology: a new design
Richard Kaplan, Timothy Maughan, Angela Crook, et al.
The Lancet. Gastroenterology & Hepatology
|
July 30, 2021
The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study
Raymond Hugo Henderson, Declan French, Timothy Maughan, et al.
Journal of Clinical Pathology
|
September 10, 2015
Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial
Susan D Richman, Richard Adams, Phil Quirke, et al.
British Journal of Cancer
|
June 17, 2022
Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer
Taiki Hashimoto, Daisuke Takayanagi, Junpei Yonemaru, et al.
Scientific Reports
|
September 19, 2019
The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression
Rachael Thomas, Davide Trapani, Lily Goodyer-Sait, et al.
BMC Cancer
|
February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)
Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
Clinical Trials (London, England)
|
August 24, 2017
Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols
Mahesh Kb Parmar, Matthew R Sydes, Fay H Cafferty, et al.
The Lancet. Oncology
|
April 13, 2013
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial
Roger D James, Robert Glynne-Jones, Helen M Meadows, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 20, 2013
A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
Gary Middleton, Sarah Brown, Catherine Lowe, et al.
BMC Cancer
|
April 17, 2015
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma
Somnath Mukherjee, Christopher N Hurt, Sarah Gwynne, et al.
Page
of 3